Awardee OrganizationUNIV OF MASSACHUSETTS MED SCH WORCESTER
Description
Abstract Text
The overall goal of this research program is to understand the process
of signal transduction by the epidermal growth factor (EGF) receptor.
A specific focus of this proposal is to define the mechanism and
significance of the phosphorylation of the EGF receptor at the negative
regulatory site Ser (1046/7). It is anticipated that this research will
add significant new information to two different areas of basic research
in cell biology: 1)signal transduction by growth factor receptors; and
2) the molecular mechanism of receptor desensitization. Progress in this
research will increase the understanding of the mechanisms that account
for the increased cellular proliferation caused by growth factors. This
information represents a basis for the design of rational therapeutic
strategies for the control of proliferative diseases of epithelial
tissues such as cancer of the cervix and breast. There are four Specific
Aims:
1. To identify growth factor-stimulated protein kinases that cause the
phosphorylation of the EGF receptor at Ser-1046/7. The molecular
mechanism that accounts for the EGF-stimulated phosphorylation of the EGF
receptor at Ser (1046/7) has not been established. The focus of this
specific aim is to define the mechanism by which growth factors regulate
the phosphorylation state of the EGF receptor at this site.
2. To test the hypothesis that the phosphorylation of the EGF receptor
at Ser-1046/7 causes desensitization of EGF receptor signal transduction.
Increased phosphorylation of the EGF receptor at Ser (1046/7) has been
shown to correlate with EGF receptor desensitization. We will examine
whether there is a causal relationship between EGF receptor
phosphorylation at Ser (1046/7) and the process of desensitization.
3. To investigate the physiological significance of EGF receptor
desensitization during signal transduction. Rapid desensitization of the
EGF receptor occurs when cultured cells are incubated with low mitogenic
concentrations of EGF. However, the biological significance of receptor
desensitization during EGF-stimulated cellular proliferation has not been
established. We shall test the hypothesis that receptor desensitization
is relevant to the process of signal transduction in EGF-treated cells.
4. To test the hypothesis that the association of signalling molecules
with the EGF receptor is regulated by phosphorylation at Ser-1046/7. The
phosphorylation site Ser(1046/7) is located within an important effector
domain at the COOH terminus of the EGF receptor that: a) binds to
signalling molecules; and b) is required for signal transduction. We
shall test the hypothesis that Ser(1046/7 phosphorylation regulates the
association of proteins with the EGF receptor.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
SDS polyacrylamide gel electrophoresisbiological signal transductionepidermal growth factorgrowth factorgrowth factor receptorslaboratory mouselaboratory rabbitphosphorylationprotein kinasereceptor sensitivitywestern blottings
No Sub Projects information available for 5R01CA058396-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA058396-02
Patents
No Patents information available for 5R01CA058396-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA058396-02
Clinical Studies
No Clinical Studies information available for 5R01CA058396-02
News and More
Related News Releases
No news release information available for 5R01CA058396-02
History
No Historical information available for 5R01CA058396-02
Similar Projects
No Similar Projects information available for 5R01CA058396-02